Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed Nov 14, 2025 · 10-Q · 45 days after period end · 0001493152-25-022641
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$5.73M | -$5.88M | -$3.90M | $1.61M |
| EPS Diluted | -$0.03 | -$0.03 | -$0.03 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end
